19.94
Doximity Inc stock is traded at $19.94, with a volume of 3.47M.
It is up +2.84% in the last 24 hours and down -17.81% over the past month.
Doximity Inc is a digital platform for U.S. medical professionals. The cloud-based platform provides members with tools specifically built for medical professionals, enabling them to collaborate with their colleagues, securely coordinate patient care, conduct virtual patient visits, stay up-to-date with the latest medical news and research, and manage their careers and on-call schedules.
See More
Previous Close:
$19.39
Open:
$19.3
24h Volume:
3.47M
Relative Volume:
0.95
Market Cap:
$3.65B
Revenue:
$637.78M
Net Income/Loss:
$239.40M
P/E Ratio:
16.74
EPS:
1.1909
Net Cash Flow:
$307.21M
1W Performance:
+5.11%
1M Performance:
-17.81%
6M Performance:
-60.45%
1Y Performance:
-61.10%
Doximity Inc Stock (DOCS) Company Profile
Name
Doximity Inc
Sector
Industry
Phone
(650) 549-4330
Address
500 THIRD STREET, SUITE 510, SAN FRANCISCO
Compare DOCS vs VEEV, BTSG, TEM, HQY, HNGE
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
DOCS
Doximity Inc
|
19.94 | 3.55B | 637.78M | 239.40M | 307.21M | 1.1909 |
|
VEEV
Veeva Systems Inc
|
160.17 | 25.83B | 3.20B | 908.91M | 1.39B | 5.4168 |
|
BTSG
Brightspring Health Services Inc
|
58.50 | 11.25B | 13.65B | 169.86M | 412.12M | 1.0758 |
|
TEM
Tempus Ai Inc
|
46.18 | 8.35B | 1.36B | -302.91M | -219.93M | -1.7182 |
|
HQY
Healthequity Inc
|
88.11 | 7.25B | 1.31B | 215.20M | 408.32M | 2.4627 |
|
HNGE
Hinge Health Inc
|
55.25 | 4.27B | 646.34M | -512.40M | 202.76M | -6.6871 |
Doximity Inc Stock (DOCS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-20-26 | Downgrade | Truist | Buy → Hold |
| Apr-08-26 | Downgrade | Evercore ISI | Outperform → In-line |
| Feb-09-26 | Upgrade | Canaccord Genuity | Hold → Buy |
| Feb-06-26 | Upgrade | JP Morgan | Underweight → Neutral |
| Jan-20-26 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Jan-09-26 | Initiated | RBC Capital Mkts | Outperform |
| Jan-08-26 | Upgrade | Truist | Hold → Buy |
| Dec-15-25 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Dec-09-25 | Initiated | Barclays | Overweight |
| Nov-21-25 | Upgrade | Raymond James | Outperform → Strong Buy |
| Nov-13-25 | Initiated | BMO Capital Markets | Market Perform |
| Oct-27-25 | Upgrade | BofA Securities | Neutral → Buy |
| Oct-10-25 | Downgrade | JP Morgan | Neutral → Underweight |
| Oct-01-25 | Downgrade | Goldman | Neutral → Sell |
| Jul-09-25 | Upgrade | Evercore ISI | In-line → Outperform |
| Jun-02-25 | Upgrade | BTIG Research | Neutral → Buy |
| Feb-07-25 | Upgrade | Leerink Partners | Market Perform → Outperform |
| Feb-07-25 | Upgrade | Piper Sandler | Neutral → Overweight |
| Dec-20-24 | Initiated | Stephens | Equal-Weight |
| Dec-04-24 | Initiated | Mizuho | Neutral |
| Nov-15-24 | Initiated | Goldman | Neutral |
| Nov-14-24 | Upgrade | Morgan Stanley | Underweight → Equal-Weight |
| Nov-13-24 | Downgrade | Canaccord Genuity | Buy → Hold |
| Nov-08-24 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Nov-08-24 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Oct-15-24 | Upgrade | Barclays | Equal Weight → Overweight |
| Aug-09-24 | Upgrade | Needham | Hold → Buy |
| Jul-18-24 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| Apr-25-24 | Upgrade | JP Morgan | Underweight → Neutral |
| Feb-26-24 | Initiated | Leerink Partners | Market Perform |
| Jan-03-24 | Initiated | Barclays | Equal Weight |
| Jan-02-24 | Upgrade | BofA Securities | Underperform → Neutral |
| Aug-09-23 | Downgrade | Guggenheim | Buy → Neutral |
| Aug-09-23 | Downgrade | Needham | Buy → Hold |
| Aug-03-23 | Downgrade | Piper Sandler | Overweight → Neutral |
| May-01-23 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Jan-06-23 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Oct-31-22 | Initiated | Wells Fargo | Overweight |
| Oct-24-22 | Initiated | Evercore ISI | In-line |
| Oct-13-22 | Initiated | BTIG Research | Neutral |
| Sep-16-22 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Sep-07-22 | Initiated | Truist | Hold |
| Aug-05-22 | Downgrade | BofA Securities | Neutral → Underperform |
| Jul-28-22 | Initiated | Berenberg | Buy |
| May-18-22 | Reiterated | BofA Securities | Neutral |
| May-18-22 | Reiterated | Goldman | Buy |
| May-18-22 | Reiterated | Guggenheim | Buy |
| May-18-22 | Reiterated | Jefferies | Buy |
| May-18-22 | Reiterated | Morgan Stanley | Equal-Weight |
| May-18-22 | Reiterated | Needham | Buy |
| Apr-07-22 | Initiated | Guggenheim | Buy |
| Apr-04-22 | Initiated | BofA Securities | Neutral |
| Feb-11-22 | Initiated | Goldman | Buy |
| Dec-14-21 | Downgrade | JP Morgan | Neutral → Underweight |
| Dec-02-21 | Initiated | Jefferies | Buy |
| Nov-17-21 | Initiated | Robert W. Baird | Outperform |
| Nov-10-21 | Reiterated | Canaccord Genuity | Buy |
| Nov-10-21 | Reiterated | Goldman | Neutral |
| Nov-10-21 | Reiterated | Morgan Stanley | Equal-Weight |
| Nov-10-21 | Reiterated | Needham | Buy |
| Nov-10-21 | Reiterated | Piper Sandler | Overweight |
| Aug-26-21 | Downgrade | JP Morgan | Overweight → Neutral |
| Jul-19-21 | Initiated | Canaccord Genuity | Buy |
| Jul-19-21 | Initiated | Goldman | Neutral |
| Jul-19-21 | Initiated | JP Morgan | Overweight |
| Jul-19-21 | Initiated | Morgan Stanley | Equal-Weight |
| Jul-19-21 | Initiated | Piper Sandler | Overweight |
| Jul-19-21 | Initiated | Raymond James | Outperform |
| Jul-19-21 | Initiated | SVB Leerink | Outperform |
| Jul-19-21 | Initiated | William Blair | Outperform |
View All
Doximity Inc Stock (DOCS) Latest News
Doximity AI Push Reshapes Healthcare Tech On Russell 1000 - Kalkine Media
Doximity, Inc. (DOCS) Stock Report: Analyst Ratings Point To A Promising 26% Upside - DirectorsTalk Interviews
Can Russell 1000 Pressure Weigh on Doximity Shares? - Kalkine Media
Doximity Stock Just Got Crushed. Is This a Rare Chance to Buy a High-Quality Growth Company on Sale? - Yahoo Finance
Doximity Stock Just Got Crushed. Is This a Rare Chance to Buy a High-Quality Growth Company on Sale? - The Motley Fool
Doximity hits an all-time low after Q4 results; KeyBanc downgrades - MSN
Doximity’s SWOT analysis: stock faces pressure from AI spending, slowing growth - Investing.com
Doximity shares hit record low as soft guidance and AI margin pressures spark 25% plunge - MSN
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Doximity, Inc. (DOCS) And Encourages Stockholders to Reach Out - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation int - The National Law Review
Doximity forecasts fiscal 2027 revenue of $664M-$676M amid 'AI investment year' and softer pharma ad visibility - MSN
Handelsbanken Fonder AB Sells 315,900 Shares of Doximity, Inc. $DOCS - MarketBeat
Doximity (DOCS) Institutional Ownership 2026 $DOCS - MarketBeat
Doximity to Present at the William Blair 46th Annual Growth Stock Conference - 01net
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Doximity, Inc.DOCS - PR Newswire
5 Revealing Analyst Questions From Doximity’s Q1 Earnings Call - Yahoo Finance
AI Reliance Poses Growing Operational, Regulatory, and Reputational Risks for Doximity - TipRanks
Doximity Leadership Shift And AI Push Reframe Growth And Valuation Outlook - Yahoo Finance
Stock market today: S&P 500, Dow, Nasdaq futures gain as Trump clears NVDA's H200 sales to China—Cisco Systems, Doximity in focus (updated) - MSN
DOCS Stock Price, Quote & Chart | DOXIMITY INC-CLASS A (NYSE:DOCS) - ChartMill
Is It Time To Reassess Doximity (DOCS) After Its Sharp Share Price Slide? - simplywall.st
1,246 Doximity (DOCS) shares withheld to cover RSU taxes for interim PFO - Stock Titan
Doximity (NYSE: DOCS) CEO granted PSUs while shares withheld for tax - Stock Titan
Doximity (DOCS) outlines physician network, Clinical AI Suite and main business risks - Stock Titan
Why Are Doximity (DOCS) Shares Soaring Today - Yahoo Finance
J.P. Morgan Upgrades Doximity(DOCS.US) to Hold Rating, Cuts Target Price to $28 - Moomoo
Truist Financial Maintains Doximity(DOCS.US) With Hold Rating, Cuts Target Price to $19 - Moomoo
Doximity (DOCS) Q1 CY2026 Deep Dive: AI Investments Accelerate Amid Macro and Policy Headwinds - Yahoo Finance
Why Doximity (DOCS) Shares Are Sliding Today - Yahoo Finance
Northwestern Mutual Wealth Management Co. Purchases 1,298,492 Shares of Doximity, Inc. $DOCS - MarketBeat
Doximity (DOCS) Is Down 27.0% After Softer 2027 Outlook And Higher AI SpendWhat's Changed - Sahm
Doximity Stock Hits Day Low of $17.16 Amid Price Pressure - Markets Mojo
Another Wall Street analyst slashes Doximity stock price outlook - thestreet.com
Doximity stock falls on Q4 earnings miss, revenues beat, margins down - MSN
Doximity shares plunge 20% on soft guidance and AI margin pressures - MSN
Doximity, Inc. 2026 Q4ResultsEarnings Call Presentation (NYSE:DOCS) 2026-05-16 - Seeking Alpha
Assessing Doximity (DOCS) Valuation After A Steep Share Price Decline - Yahoo Finance
Doximity (DOCS) Margin Compression Challenges Bullish AI Growth Narratives After FY 2026 Results - Sahm
Barclays Downgrades Doximity (NYSE:DOCS) to Hold - MarketBeat
Raymond James Upgrades Doximity (DOCS) - MSN
Why Is Doximity Stock Trending Right Now - Kalkine Media
RBC Capital Maintains Doximity(DOCS.US) With Buy Rating, Cuts Target Price to $28 - Moomoo
Doximity Earnings Call: Cash‑Rich, Slower Growth, Big AI Bet - The Globe and Mail
Doximity Analyst Ratings and Price Targets | NYSE:DOCS - Benzinga
Doximity Inc (DOCS) Stock Price, Quote, News & History - Benzinga
Doximity (DOCS) founders report combined stakes equal to 77% voting power - Stock Titan
Doximity, Inc. Stock 12‑Month Price Target Cut to $24.92, Implies 38% Upside - TradingView
Leerink Partners Maintains Doximity(DOCS.US) With Buy Rating, Maintains Target Price $25 - Moomoo
Doximity (NYSE:DOCS) Trading 8.6% HigherStill a Buy? - MarketBeat
Doximity Earnings: Strong AI Signals, But Monetization Still Pending (NYSE:DOCS) - Seeking Alpha
DOCS Teams Up With Aledade to Bring Clinical AI to Value-Based Care - Zacks Investment Research
Doximity Inc Stock (DOCS) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):